Cargando…

Study design of VGOAL-J: an observational, prospective cohort study to assess effectiveness of vortioxetine on goal achievement and work productivity in patients with MDD in Japan

INTRODUCTION: Goal attainment scaling (GAS) is a method to assess the patient experience of whether a treatment is successful and capture outcomes across a diverse range of goal areas. However, this approach has not yet been used in assessing the treatment of Major Depressive Disorder (MDD) in Japan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, K., Moriguchi, Y., Ren, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566117/ http://dx.doi.org/10.1192/j.eurpsy.2022.1411

Ejemplares similares

The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
por: Papalexi, E., et al.
Publicado: (2021)

A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)
por: Ng, Chong Guan, et al.
Publicado: (2023)

Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD)
por: Montano, C Brendan, et al.
Publicado: (2022)

Patient attitudes toward and goals for MDD treatment: a survey study
por: McNaughton, Emily C, et al.
Publicado: (2019)

Improvements in mood symptoms, cognitive symptoms and functioning in outpatients with mdd in greece treated with vortioxetine: A patient-rated evaluation
por: Galanopoulos, A., et al.
Publicado: (2021)

A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD
por: Mahableshwarkar, Atul R., et al.
Publicado: (2015)

Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)
por: Chokka, Pratap, et al.
Publicado: (2019)

Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
por: Inoue, Takeshi, et al.
Publicado: (2021)

Early improvement of painful symptoms in MDD: is there an association in achieving remission?
por: Bär, Karl-Jürgen
Publicado: (2007)

Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
por: Inoue, Takeshi, et al.
Publicado: (2021)

Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan (PERFORM-J): Protocol for a Prospective Cohort Study
por: Sumiyoshi, Tomiki, et al.
Publicado: (2018)

Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
por: Watanabe, Koichiro, et al.
Publicado: (2022)

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
por: Levada, Oleg A., et al.
Publicado: (2020)

Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study
por: Shrashimirova, Milena, et al.
Publicado: (2023)

PS83. Impact of Vortioxetine on Functional Capacity in MDD Patients with Subjective Cognitive Dysfunction: A Post-hoc Analysis of the University of California San Diego Performance-Based Skills Assessment
por: Jacobson, William, et al.
Publicado: (2016)

Why is Diagnosing MDD Challenging?
Publicado: (2016)

Integrating Turkish Work and Achievement Goals With Schwartz’s Human Values
por: Tevrüz, Suna, et al.
Publicado: (2015)

POSTPARTUM GAD IS A RISK FACTOR FOR POSTPARTUM MDD: THE COURSE AND LONGITUDINAL RELATIONSHIPS OF POSTPARTUM GAD AND MDD
por: Prenoveau, Jason, et al.
Publicado: (2013)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
por: Novick, Diego, et al.
Publicado: (2017)

Relationship of Mean Platelet Volume To MDD: A Retrospective Study
Publicado: (2017)

From MDD concepts to experiments and illustrations
por: Babau, Jean-Philippe, et al.
Publicado: (2006)

The neurocognitive profile of post‐traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
por: Koopowitz, Sheri‐Michelle, et al.
Publicado: (2021)

Achieve your goals
por: Smith, Andy
Publicado: (2006)

Is the main goal of mastication achieved after orthodontic treatment? A prospective longitudinal study
por: Gameiro, Gustavo Hauber, et al.
Publicado: (2017)

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
por: Chen, Grace, et al.
Publicado: (2017)

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients
por: Findling, Robert L., et al.
Publicado: (2017)

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population
por: Miao, Jia, et al.
Publicado: (2019)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Clinical effectiveness of vortioxetine in postcovid syndrome
por: Vikarenko, M., et al.
Publicado: (2022)

An Examination of Psychomotor Disturbance in Current and Remitted MDD: An RDoC Study
por: Shankman, Stewart A., et al.
Publicado: (2020)

Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
por: Mattingly, G., et al.
Publicado: (2021)

The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2019)

Comparison of Electroencephalography (EEG) Coherence between Major Depressive Disorder (MDD) without Comorbidity and MDD Comorbid with Internet Gaming Disorder
por: Youh, Joohyung, et al.
Publicado: (2017)

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2022)

Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism—In Vitro Study
por: Ľupták, Matej, et al.
Publicado: (2022)

Leaders’ achievement goals predict employee burnout above and beyond employees’ own achievement goals
por: Sijbom, Roy B. L., et al.
Publicado: (2018)

Early supplemental parenteral nutrition for the achievement of nutritional goals in subarachnoid hemorrhage patients: An observational cohort study
por: Kofler, Mario, et al.
Publicado: (2022)

FMRI study of implicit emotional face processing in patients with MDD with melancholic subtype
por: Kustubayeva, Almira, et al.
Publicado: (2023)

Crystal structures of vortioxetine and its methanol monosolvate
por: Zhou, Xin-Bo, et al.
Publicado: (2015)

Which Cognitive Domains are Improved by Treatment with Vortioxetine?
por: Harrison, John E, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_462gi009oc1scv6fnkbosesckn